Hypotension: The second modifiable risk factor in glaucoma
February 4th 2023According to the Ocular Hypertension Treatment Study, 5 risk factors are associated with high or low risk for primary open-angle glaucoma (POAG), with the intraocular pressure (IOP) historically being the “gold standard” and only modifiable risk factor.
Decrease in endothelial cell density continues after iris-fixated phakic IOL explantation
January 16th 2023The research team retrospectively studied the long-term corneal endothelial cell changes and visual outcomes after this iris-fixated phakic IOL was explanted in patients with endothelial damage and investigated any potential predictors of endothelial injury.
FDA approves intravenous injection for delayed onset of stage 3 type 1 diabetes
November 18th 2022Teplizumab may work by binding to certain immune system cells that attack insulin-producing cells and increase the proportion of cells that help moderate the immune response, thus delaying progression to stage 3 type 1 diabetes.
Study: Abnormal ophthalmologic findings in pediatric and adolescent patients
October 18th 2022Awareness of visual impairment in clinical practice is suboptimal, and adherence to ophthalmologic evaluation needs to be improved. The prospective cohort study in the Netherlands included 170 children aged 0 to 18 years with a newly diagnosed brain tumor.